[ 1 ] Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009;9(4):228–36. link1

[ 2 ] Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT, Andrasevic´ AT, et al. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis 2017;17(2):153–63. link1

[ 3 ] WHO. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics [Internet]. Geneva: WHO; 2017 [cited 2020 Nov 25]. Available from: https://www.who.int/medicines/ publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf?ua=1. link1

[ 4 ] Cerqueira GC, Earl AM, Ernst CM, Grad YH, Dekker JP, Feldgarden M, et al. Multi-institute analysis of carbapenem resistance reveals remarkable diversity, unexplained mechanisms, and limited clonal outbreaks. Proc Natl Acad Sci USA 2017;114(5):1135–40. link1

[ 5 ] Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 2012;25(4):682–707. link1

[ 6 ] Rojas LJ, Salim M, Cober E, Richter SS, Perez F, Salata RA, et al. Colistin resistance in carbapenem-resistant Klebsiella pneumoniae: laboratory detection and impact on mortality. Clin Infect Dis 2017;64(6):711–8. link1

[ 7 ] Cheng VCC, Chen JHK, So SYC, Wong SCY, Chau PH, Wong LMW, et al. A novel risk factor associated with colonization by carbapenemase-producing enterobacteriaceae: use of proton pump inhibitors in addition to antimicrobial treatment. Infect Control Hosp Epidemiol 2016;37(12):1418–25. link1

[ 8 ] Zheng B, Xu H, Lv T, Guo L, Xiao Y, Huang C, et al. Stool samples of acute diarrhea inpatients as a reservoir of ST11 hypervirulent KPC-2-producing Klebsiella pneumoniae. mSystems 2020;5(3):e00498–20.

[ 9 ] Laupland KB, Church DL. Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev 2014;27 (4):647–64. link1

[10] Satlin MJ, Chavda KD, Baker TM, Chen L, Shashkina E, Soave R, et al. Colonization with levofloxacin-resistant extended-spectrum beta-lactamaseproducing Enterobacteriaceae and risk of bacteremia in hematopoietic stem cell transplant recipients. Clin Infect Dis 2018;67(11):11. link1

[11] CDC. Antibiotic resistance threats in the United States, 2013 [Internet]. Atlanta: CDC; 2013 [cited 2020 Nov 25]. Available from: http://www. cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf. link1

[12] White AR. The British society for antimicrobial chemotherapy resistance surveillance project: a successful collaborative model. J Antimicrob Chemother 2008;62(Suppl 2):ii3–14. link1

[13] Zhang R, Liu L, Zhou H, Chan EW, Li J, Fang Y, et al. Nationwide surveillance of clinical carbapenem-resistant Enterobacteriaceae (CRE) strains in China. EBioMedicine 2017;19:98–106. link1

[14] Xu A, Zheng B, Xu YC, Huang ZG, Zhong NS, Zhuo C. National epidemiology of carbapenem-resistant and extensively drug-resistant Gram-negative bacteria isolated from blood samples in China in 2013. Clin Microbiol Infect 2016;22 (Suppl 1):S1–8. link1

[15] Zhang Y, Wang Q, Yin Y, Chen H, Jin L, Gu B, et al. Epidemiology of carbapenem-resistant Enterobacteriaceae infections: report from the China CRE network. Antimicrob Agents Chemother 2018;62(2): e01882–17.

[16] Quan J, Zhao D, Liu L, Chen Y, Zhou J, Jiang Y, et al. High prevalence of ESBLproducing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China. J Antimicrob Chemother 2017;72(1):273–80. link1

[17] Zheng B, Chen Y, Violetta L, Xiao Y, Li L. Bloodstream infections caused by Enterobacteriaceae in China. Lancet Infect Dis 2019;19(8):810–1. link1

[18] CLSI. Performance standards for antimicrobial susceptibility testing. 27th ed. Wayne: Clinical and Laboratory Standards Institute; 2017. link1

[19] Zheng B, Zhang J, Ji J, Fang Y, Shen P, Ying C, et al. Emergence of Raoultella ornithinolytica coproducing IMP-4 and KPC-2 carbapenemases in China. Antimicrob Agents Chemother 2015;59(11):7086–9. link1

[20] Zerbino DR, Birney E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 2008;18(5):821–9. link1

[21] Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 2012;67(11):2640–4. link1

[22] Darling ACE, Mau B, Blattner FR, Perna NT. Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res 2004;14 (7):1394–403. link1

[23] Zheng B, Dong H, Xu H, Lv J, Zhang J, Jiang X, et al. Coexistence of MCR-1 and NDM-1 in clinical Escherichia coli isolates. Clin Infect Dis 2016;63(10):1393–5. link1

[24] Antipov D, Hartwick N, Shen M, Raiko M, Lapidus A, Pevzner PA. plasmidSPAdes: assembling plasmids from whole genome sequencing data. Bioinformatics 2016;32(22):3380–7. link1

[25] Delcher AL, Salzberg SL, Phillippy AM. Using MUMmer to identify similar regions in large sequence sets. Curr Protoc Bioinformatics 2003;Chapter 10: Unit 10.3.

[26] Galata V, Fehlmann T, Backes C, Keller A. PLSDB: a resource of complete bacterial plasmids. Nucleic Acids Res 2019;47(D1):D195–202.

[27] Carattoli A, Zankari E, García-Fernández A, Voldby Larsen M, Lund O, Villa L, et al. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother 2014;58 (7):3895–903. link1

[28] Holt KE, Wertheim H, Zadoks RN, Baker S, Whitehouse CA, Dance D, et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci USA 2015;112(27):E3574–81. link1

[29] Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and postanalysis of large phylogenies. Bioinformatics 2014;30(9):1312–3.

[30] Gutiérrez-Gutiérrez B, Salamanca E, de Cueto M, Hsueh PR, Viale P, Paño-Pardo JR, et al. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. Lancet Infect Dis 2017;17(7):726–34. link1

[31] Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 2012;55(7):943–50. link1

[32] Liu L, Feng Y, Long H, McNally A, Zong Z. Sequence type 273 carbapenemresistant Klebsiella pneumoniae carrying blaNDM-1 and blaIMP-4. Antimicrob Agents Chemother 2018;62(6):AAC.00160–18.

[33] Zhao F, Zhang J, Fu Y, Ruan Z, Xie X. Dissemination of extensively drugresistant and KPC-2 producing Klebsiella pneumoniae isolated from bloodstream infections. J Infect Dev Countries 2015;9(9):1016–21.

[34] Myat TO, Hannaway RF, Zin KN, Htike WW, Win KK, Crump JA, et al. ESBL- and carbapenemase-producing Enterobacteriaceae in patients with bacteremia, Yangon, Myanmar, 2014. Emerg Infect Dis 2017;23(5):857–9. link1

[35] Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y. ST11, the dominant clone of KPCproducing Klebsiella pneumoniae in China. J Antimicrob Chemother 2011;66 (2):307–12.

[36] Shen P, Berglund B, Chen Y, Zhou Y, Xiao T, Xiao Y, et al. Hypervirulence markers among non-ST11 strains of carbapenem- and multidrug-resistant Klebsiella pneumoniae isolated from patients with bloodstream infections. Front Microbiol 2020;11:1199.

[37] Zhou K, Xiao T, David S, Wang Q, Zhou Y, Guo L, et al. Novel subclone of carbapenem-resistant Klebsiella pneumoniae sequence type 11 with enhanced virulence and transmissibility, China. Emerg Infect Dis 2020;26 (2):289–97. link1

[38] Huang Y, Yu X, Xie M, Wang X, Liao K, Xue W, et al. Widespread dissemination of carbapenem-resistant Escherichia coli sequence type 167 strains harboring blaNDM-5 in clinical settings in China. Antimicrob Agents Chemother 2016;60 (7):4364–8. link1

[39] Zong Z, Fenn S, Connor C, Feng Y, McNally A. Complete genomic characterization of two Escherichia coli lineages responsible for a cluster of carbapenem-resistant infections in a Chinese hospital. J Antimicrob Chemother 2018;73(9):2340–6.

[40] Cuzon G, Bonnin RA, Nordmann P. First identification of novel NDM carbapenemase, NDM-7, in Escherichia coli in France. PLoS One 2013;8(4): e61322.

[41] Grönthal T, Österblad M, Eklund M, Jalava J, Nykäsenoja S, Pekkanen K, et al. Sharing more than friendship-transmission of NDM-5 ST167 and CTX-M-9 ST69 Escherichia coli between dogs and humans in a family, Finland, 2015. Euro Surveill 2018;23(27):1700497.

[42] Paskova V, Medvecky M, Skalova A, Chudejova K, Bitar I, Jakubu V, et al. Characterization of NDM-encoding plasmids from Enterobacteriaceae recovered from Czech hospitals. Front Microbiol 2018;9:1549.

[43] Giufrè M, Errico G, Accogli M, Monaco M, Villa L, Distasi MA, et al. Emergence of NDM-5-producing Escherichia coli sequence type 167 clone in Italy. Int J Antimicrob Agents 2018;52(1):76–81. link1

[44] Sun J, Yang RS, Zhang Q, Feng Y, Fang LX, Xia J, et al. Co-transfer of blaNDM-5 and mcr-1 by an IncX3-X4 hybrid plasmid in Escherichia coli. Nat Microbiol 2016;1 (12):16176. link1

[45] Schubert S, Cuenca S, Fischer D, Heesemann J. High-pathogenicity island of Yersinia pestis in Enterobacteriaceae isolated from blood cultures and urine samples: prevalence and functional expression. J Infect Dis 2000;182 (4):1268–71. link1

[46] Lam MMC, Wick RR, Wyres KL, Gorrie CL, Judd LM, Jenney AWJ, et al. Genetic diversity, mobilisation and spread of the yersiniabactin-encoding mobile element ICEKp in Klebsiella pneumoniae populations. Microb Genom 2018;4 (9):e000196.

[47] Gu D, Dong N, Zheng Z, Lin D, Huang M, Wang L, et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis 2018;18 (1):37–46. link1